About Us

Our Foundation & Reason to Exist

Sonix Medical Devices, Inc., is a USA based life science company. Sonix Medical Devices develops innovative healthcare solutions and treatments in the areas of highly unmet medical needs by bridging the gap between disruptive products and real-world patient access. Our philosphy is to build our company that brings a positive change in the world with our core healthcare technologies. To us it is about stopping a global healthcare disaster and to forge a path forward to bring creative solutions to end Antimicrobial Resistance. By preventing bacterial infections, we can save millions of lives and by doing so we will achieve financial goals for our investors and our company.

Our portfolio currently includes multiple patented technologies and in-licensed products in the medical device’s category.

Sonix-A8 is a novel and patented technology platform specifically developed to prevent and control bacterial infections. This non-pharmaceutical option is a potential game changer in the fight against Antimicrobial Resistance (AMR).

Our products and technology aims to revolutionize the prevention and control of Surgical Site Infections (SSI’s) and Hospital Associated Infections (HAI’s). We measure our success by delivering global impact through our innovative products and technologies and ensuring best outcomes for patients.

Our Mission

To develop innovative products and technologies to prevent and control bacterial infections and to combat Antimicrobial Resistance (AMR) with global access to treatments.

Our Vision

To have a global impact by eliminating AMR through our innovative technologies and product solutions.

Our Team

t1

Vipula Tailor, MS, MBA, Founder & Chief Executive Officer

Entrepreneur with successful previous two exits and a pharmaceutical industry executive with over 20 years of international business development, licensing, R&D and commercialization experience in biotech, pharmaceuticals, medical devices/diagnostics and healthcare areas. Led strategic and organic growth of portfolio of products and companies and closed deals over $500MM. Led acquisitions and mergers for fortune 100 medical devices companies. Held leadership roles at Pfizer (Wyeth), GSK, Johnson and Johnson, Kimberly-Clark and Vertex. Vipula received Tata scholarship and was awarded Robert White fellowship by the Society of Immunology UK. She was the winner of 2017 Venture Forum Annual Contest, recipient of 2018 International Life Sciences Award for Best Pharmaceutical Technology Provider and Most Inspirational Pharmaceutical Entrepreneur. Vipula has lived and worked in India, UK, Germany, Switzerland, Canada and USA.

Capture(2)

Mark Schafer, Phd, Chief Technical Officer

Mark Schafer is a leading ultrasound industry expert. He holds 25 patents and has served in senior management roles for many early stage companies developing innovative ultrasonic devices. Mark was most recently the CTO of Sound Surgical Technologies, a successful cosmetic ultrasound company. He earned a BSEE from MIT, an MS in Acoustics from Penn State and a PhD in Biomedical Engineering from Drexel University.

t2

Aditee Dalvi, MD, MBA, Head of R&D

Accomplished biopharmaceutical executive with extensive experience in development of diagnostics and assay design. Aditee developed and managed CLIA labs and identified and validated clinical biomarkers, developed companion diagnostics, and other diagnostic assay based on OMICS. She was head of Diagnostics and CLIA laboratories in her previous role and experienced in identifying variants linked to diseases. Aditee holds a MD degree from India and MBA from Boston College.

t3

Denis Grimard, M.Eng, Head of Finance & Operations

A highly experienced medical device executive with 30 plus years of proven experience with early stage start-ups to large multi-nationals in the medical device industry, with core experience in manufacturing and commercialization of products. Denis redefined the supply-chain management optimization and has contributed significantly to product development and has expansive understanding of product, process and materials. Held several leadership roles at Kimberly-Clark, and lived and worked in China, Canada and USA.

OUR MISSION

OUR VISION

OUR TEAM

COMPANY OVERVIEW

SONIX A-8 BREAKTHROUGH PATENTED TECHNOLOGY 

We use sound and light to kill bacteria living on surfaces. We can also reach and kill bacteria living below the skin’s surface where traditional treatments fail.

It is a revolutionary new approach that does not require any chemical compounds/pharmaceutical agent to kill bacteria.

CUTTING EDGE TECHNOLOGY

We are U.S. based, privately held medical device company focused on eliminating pre and post operative bacterial infections

TOP TIER TALENT

Experienced Executive Team with over 200 Products Launched

Our portfolio currently includes novel and patent protected products

  • Medical Devices
  • Wearables
  • Home Care Devices
  • Wound Healing Products

Vipula Tailor, MS, MBA, Founder & Chief Executive Officer 

Entrepreneur with successful previous two exits and a pharmaceutical industry executive with over 20 years of international business development, licensing, R&D and commercialization experience in biotech, pharmaceuticals, medical devices/diagnostics and healthcare areas. Led strategic and organic growth of portfolio of products and companies and closed deals over $500MM. Led acquisitions and mergers for fortune 100 medical devices companies. Held leadership roles at Pfizer (Wyeth), GSK, Johnson and Johnson, Kimberly-Clark and Vertex. Vipula received Tata scholarship and was awarded Robert White fellowship by the Society of Immunology UK. She was the winner of 2017 Venture Forum Annual Contest, recipient of 2018 International Life Sciences Award for Best Pharmaceutical Technology Provider and Most Inspirational Pharmaceutical Entrepreneur. Vipula has lived and worked in India, UK, Germany, Switzerland, Canada and USA.

Mark Schafer, PhD Chief Technical Officer 

Mark Schafer is a leading ultrasound industry expert. He holds 25 patents and has served in senior management roles for many early stage companies developing innovative ultrasonic devices. Mark was most recently the CTO of Sound Surgical Technologies, a successful cosmetic ultrasound company. He earned a BSEE from MIT, an MS in Acoustics from Penn State and a PhD in Biomedical Engineering from Drexel University.

Aditee Dalvi, MD, MBA, Chief Scientific Officer 

Accomplished biopharmaceutical executive with extensive experience in development of diagnostics and assay design. Aditee developed and managed CLIA labs and identified and validated clinical biomarkers, developed companion diagnostics, and other diagnostic assay based on OMICS. She was head of Diagnostics and CLIA laboratories in her previous role and experienced in identifying variants linked to diseases. Aditee holds a MD degree from India and MBA from Boston College.

Denis Grimard, M.Eng, Chief Operating Officer

A highly experienced medical device executive with 30 plus years of proven experience in everything from early stage start-ups to large multi-nationals in the medical device industry, with core experience in manufacturing and commercialization of products. Denis redefined the supply-chain management optimization and has contributed significantly to product development and has expansive understanding of product, process and materials. Held several leadership roles at Kimberly-Clark, and lived and worked in China, Canada and USA.

Tony Materna, M.Eng, Chief Financial Officer

Mr. Materna has enjoyed a 25-year career in high technology and is the veteran of seven previous start-ups, two of which have gone on to be $100 million successes. A degreed mechanical engineer, he has held marketing, sales, senior management, and CEO positions with companies in electronics, computers, AI, test equipment, biotech, consumer products and digital outdoor signage.

Sonix-A8 is innovative technology to prevent and control ALL bacterial infections and combat Antimicrobial Resistance.